Lack of Altered BECN1 Gene Expression in Iranian Patients with Acute Myeloid Leukemia

Acute myeloid leukemia (AML), one of the most prevalent leukemia types in adults, demonstrates great heterogeneity in molecular and clinical terms. Hence, there is a necessity to the mechanisms involved in AML generation in order to determine optimal treatment. This cross sectional study aimed to as...

Descripción completa

Detalles Bibliográficos
Autores principales: Keyvan, Ladan, Bidoki, Seyed Kazem, Abdollahi, Davood Zare, Mansouri, Neda, Hashemi, Mehrdad, Tabatabaei, SA Mortazavi, Fardmanesh, Hediyeh, Meimandi, Mansour, Ayatollahi, Seyed Majid, Movafagh, Abolfazl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454654/
https://www.ncbi.nlm.nih.gov/pubmed/28124883
http://dx.doi.org/10.22034/APJCP.2016.17.12.5173
Descripción
Sumario:Acute myeloid leukemia (AML), one of the most prevalent leukemia types in adults, demonstrates great heterogeneity in molecular and clinical terms. Hence, there is a necessity to the mechanisms involved in AML generation in order to determine optimal treatment. This cross sectional study aimed to assess changes in BECN1 gene expression in with blood samples from 30 AML patients, compared with samples from 15 healthy persons. RNA was extracted and cDNA was synthesized and Real Time PCR applied to determine BECN1 gene expression. The results showed no significant differences in BECN1 gene expression between patients with AML and normal controls (P > 0.05). It appears that expression of BECN1 does not play a significant role in genesis of AML leukemia.

Ejemplares similares